Immune system ontogeny and developmental immunotoxicology

Immunotoxicology and Immunopharmacology, Third Edition

Volumn , Issue , 2006, Pages 327-346

  Smialowicz, Ralph J ^a   Brundage, Kathleen M ^b   Barnett, John B ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 38449120986     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (132)

1. Prater, M.R., Blaylock, B.L., Holladay, S.D. The mouse as a model for developmental immunotoxicology, Developmental Immunotoxicology, CRC Press, Boca Raton, Florida, 2005, chap. 4.
2. EPA, U.S. Environmental Protection Agency, Prenatal Developmental Toxicity Study, Health Effects Test Guidelines, OPPTS 870.3700, EPA 712-C-98-207, 1998a. http://www.epa.gov/opptsfrs/OPPTS_Harmonized/870_Health_Effects_Test_Guidelines/Series/870-6300.pdf
3. EPA, U.S. Environmental Protection Agency, Reproductive and Fertility Effects, Health Effects Test Guidelines, OPPTS 870.3800, EPA 712-C-98-208, 1998b. http://www.epa.gov/opptsfrs/OPPTS_Harmonized/870_Health_Effects_Test_Guidelines/Series/870-6300.pdf
4. EPA, U.S. Environmental Protection Agency, Developmental Neurotoxicity Study, Health Effects Test Guidelines, OPPTS 870.6300, EPA 712-C-98-239, 1998c. http://www.epa.gov/opptsfrs/OPPTS_Harmonized/870_Health_Effects_Test_Guidelines/Series/870-6300.pdf
5. OECD, Organization for Economic Cooperation and Development, Guideline 414, Prenatal Developmental Toxicity Study, 2001a.
6. OECD, Organization for Economic Cooperation and Development, Guideline 416, Two Generation Reproduction Toxicity Study, 2001b.
7. FDA, U.S. Food and Drug Administration, Toxicological Principles for the Safety of Food Ingredients, Redbook 2000. http://www.cfsan.fda.gov/redbook/red-toca.html.
8. Smialowicz R.J., et al., Immunotoxicity of tributyltin oxide in rats exposed as adults or pre-weanlings, Toxicology, 57, 97, 1989.
9. Chapin R.E., et al., The effects of perinatal/juvenile methoxychlor exposure on adult rat nervous, immune and reproductive system function, Fundam. Appl. Toxicol., 40, 138, 1997.
10. Chapin R.E. The use of the rat in developmental immunotoxicology studies, Hum. Exp. Toxicol., 21, 51, 2002.
11. NRC, National Research Council, Pesticides in the Diets of Infants and Children, National Academy Press, Washington, DC, 1993.
12. ILSI, International Life Sciences Institute, “Research Needs on Age-related Differences in Susceptibility to Chemical Toxicants.” Report of an ILSI Risk Science Institute Working Group. Washington, DC: ILSI Risk Science Institute, 1996.
13. FQPA, 1996. Food Quality Protection Act of 1996, U.S. Public Law 104-170.
14. SDWA, 1996. Safe Drinking Water Act Amendment of 1996, U.S. Public Law 104-182.
15. Landreth, K.S. and Dodson, S.V.M., Development of the rodent immune system, Developmental Immunotoxicology, CRC Press, Boca Raton, Florida, 2005, chap. 1.
16. Rosen, F.S., Cooper, M.D., Wedgwood, R.J.P. The primary immunodeficiencies, New England Journal of Medicine, 333, 431, 1995.
17. Holladay, S.D. and Smialowicz, R.J., Development of the murine and human immune system: differential effects of immunotoxicants depend on time of exposure, Environ. Health Perspect., 108 (Suppl. 3), 463, 2000.
18. Luster, M.I., Dean, J.H., and Germolec, D.R. Consensus workshop on methods to evaluate developmental immunotoxicity, Environ. Health Perspect., 111, 579, 2003.
19. Holsapple, M.P., et al., A proposed testing framework for developmental immunotoxicology (DIT), Toxicol. Sci., 83, 18, 2005.
20. Migliaccio, G., et al., Human embryonic hemopoiesis, kinetics of progenitors and precursors underlying the yolk sac-liver transition, J. Clin. Invest., 78, 51, 1986.
21. Palis, J. and Yoder, M.C. Yolk-sac hematopoiesis: the first blood cells of mouse and man, Exp. Hematol., 29, 927, 2001.
22. Niimi, G., et al., A light and electron microscopic study of the mouse visceral yolk sac endodermal cells in the middle and late embryonic periods, showing the possibility of definitive erythropoiesis, Ann. Anat., 184, 425, 2002.
23. Alvarez-Silva, M., et al., Mouse placenta is a major hematopoietic organ, Development, 130, 5437, 2003.
24. Lim, F.T., Kanhai, H.H., and Falkenburg, J.H. Characterization of the human CD34+ hematopoietic progenitor cell compartment during the second trimester of pregnancy, Haematologica, 90, 173, 2005.
25. Haynes, B.F., et al., Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues, J. Exp. M.d., 168, 1061, 1988.
26. Braegger, C.P., Spencer, J., and MacDonald, T.T. Ontogenetic aspects of the intestinal immune system in man, Int. J. Clin Lab Res., 22, 1, 1992.
27. Bhide, S.A., Wadekar, K.V., and Koushik, S.A. Peyer’s patches are precocious to the appendix in human development, Dev. Immunol., 8, 159, 2001.
28. West, L.J. Defining critical windows in the development of the human immune system, Human & Experimental Toxicology 21, 499, 2002.
29. Scavelli, C., et al., Lymphatics at the crossroads of angiogenesis and lymphangiogenesis, J. Anatomy, 204, 433, 2004.
30. McVay, L.D. and Carding, S.R. Extrathymic origin of human gamma delta T cells during fetal development, J. Immunol., 157, 2873, 1996.
31. McVay, L.D., et al., The generation of human gamma delta T cell repertoires during fetal development, J. Immunol., 160, 5851, 1998.
32. Haynes, B.F. and Heinly, C.S. Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment, J. Exp. Med., 181, 1445, 1995.
33. Bonati, A., et al., T-cell receptor beta-chain gene rearrangement and expression during human thymic ontogenesis, Blood, 79, 1472, 1992.
34. Berry, S. M., et al., Circulating lymphocyte subsets in second- and third-trimester fetuses: comparison with newborns and adults, Am. J. Obstet. Gynecol., 167, 895, 1992.
35. Peakman, M., et al., Analysis of lymphocyte phenotypes in cord blood from early gestation fetuses, Clin. Exp. Immunol., 90, 345, 1992.
36. Hulstaert, F., et al., Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements, Clin. Immunol. Immunopathol., 70, 152, 1994.
37. Erkeller-Yuksel, F.M., et al., Age-related changes in human blood lymphocyte subpopulations, J. Pediatr., 120, 216, 1992.
38. Tsuji, T., et al., Efficient induction of immunoglobulin production in neonatal naive B cells by memory CD4+ T cell subset expressing homing receptor L-selectin, J. Immunol., 152, 4417, 1994.
39. Durandy, A., et al., Phenotypic and functional characteristics of human newborns’ B lymphocytes, J. Immunol., 144, 60, 1990.
40. Splawski, J.B. and Lipsky, P.E. Cytokine regulation of immunoglobulin secretion by neonatal lymphocytes, J. Clin Invest., 88, 967, 1991.
41. Akbar, A.N., et al., Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells, J. Immunol., 140, 2171, 1988.
42. Clement, L.T., Vink, P.E., and Bradley, G.E. Novel immunoregulatory functions of pheno- typically distinct subpopulations of CD4+ cells in the human neonate, J. Immunol., 145, 102, 1990.
43. Bertotto, A., et al., Activation of cord T lymphocytes. II. Cellular and molecular analysis of the defective response induced by anti-CD3 monoclonal antibody, Cell. Immunol., 127, 247, 1990.
44. Pirenne-Ansart, H., et al., Defective cytokine expression but adult-type T-cell receptor, CD8, and p56lck modulation in CD3- or CD2-activated T cells from neonates, Pediatr. Res., 37, 64, 1995.
45. Kotiranta-Ainamo, A., Rautonen, J., and Rautonen, N. Imbalanced cytokine secretion in newborns, Biol. Neonate, 85, 55, 2004.
46. Chipeta, J., et al., CD4+ and CD8+ cell cytokine profiles in neonates, older children, and adults: increasing T helper type 1 and T cytotoxic type 1 cell populations with age, Cell. Immunol., 183, 149, 1998.
47. Watson, W., et al., Immunoglobulin and cytokine production by neonatal lymphocytes, Clin. Exp. Immunol., 83, 169, 1991.
48. Adkins, B. T-cell function in newborn mice and humans, Immunol. Today, 20, 330, 1999.
49. Reddy, R.K., et al., A mixed population of immature and mature leucocytes in umbilical cord blood results in a reduced expression and function of CR3 (CD11b/CD18), Clin. Exp. Immunol., 114, 462, 1998.
50. Johnston, R.B., Jr. Function and cell biology of neutrophils and mononuclear phagocytes in the newborn infant, Vaccine, 16, 1363, 1998.
51. Holladay, S.D. and Blaylock, B.L. The mouse as a model for developmental immunotoxicology, Hum. Exp. Tox., 21, 525, 2002.
52. Smialowicz, R.J. The rat as a model in developmental immunotoxicology, Hum. Exp. Toxicol., 21, 513, 2002.
53. Rothkotter, H.J., Sowa, E., and Pabst, R. The pig as a model of developmental immunology, Hum. Exp. Tox., 21, 533, 2002.
54. Hendrickx, A.G., Makori, N., and Peterson, P. The nonhuman primate as a model of developmental immunotoxicity, Hum. Exp. Tox., 21, 537, 2002.
55. Luster, M.I., Dean, J.H., and Germolec, D.R. Consensus workshop on methods to evaluate developmental immunotoxicity, Environ. Health Perspect., 111, 579, 2003.
56. Rowley, B. and Monestier, M. Mechanisms of heavy metal-induced autoimmunity, Mol. Immunol., 42, 833, 2005.
57. Huber, T.L., et al., Haemangioblast commitment is initiated in the primitive streak of the mouse embryo, Nature, 432, 625, 2004.
58. Moore, M.A. and Metcalf, D. Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo, Br. J Haematol., 18, 279, 1970.
59. Silver, L. and Palis, J. Initiation of murine embryonic erythropoiesis: a spatial analysis, Blood, 89, 1154, 1997.
60. Palis, J., et al., Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse, Development, 126, 5073, 1999.
61. Cline, M.J. and Moore, M.A. Embryonic origin of the mouse macrophage, Blood, 39, 842, 1972.
62. Faust, N., et al., Different macrophage populations develop from embryonic/fetal and adult hematopoietic tissues, Exp. Hematol., 25, 432, 1997.
63. Hung, S.I., et al., Transient expression of Ym1, a heparin-binding lectin, during developmental hematopoiesis and inflammation, J. Leukoc. Biol., 72, 72, 2002.
64. Morioka, Y., et al., Immunophenotypic and ultrastructural heterogeneity of macrophage differentiation in bone marrow and fetal hematopoiesis of mouse in vitro and in vivo, J. Leukoc. Biol., 55, 642, 1994.
65. Dzierzak, E., Medvinsky, A., and de Bruijn, M. Qualitative and quantitative aspects of haematopoietic cell development in the mammalian embryo, Immunol. Today, 19, 228, 1998.
66. Robin, C. and Dzierzak, E. Hematopoietic stem cell enrichment from the AGM region of the mouse embryo, Methods Mol. Med., 105, 257, 2005.
67. Marcos, M.A., et al., Antigenic phenotype and gene expression pattern of lymphohemopoietic progenitors during early mouse ontogeny, J. Immunol., 158, 2627, 1997.
68. de Andres, B., et al., The first 3 days of B-cell development in the mouse embryo, Blood, 100, 4074, 2002.
69. Melchers, F. Murine embryonic B lymphocyte development in the placenta, Nature, 277, 219, 1979.
70. Ottersbach, K. and Dzierzak, E. The murine placenta contains hematopoietic stem cells within the vascular labyrinth region, Dev. Cell, 8, 377, 2005.
71. Gekas, C., et al., The placenta is a niche for hematopoietic stem cells, Dev. Cell, 8, 365, 2005.
72. Cumano, A. and Godin, I. Pluripotent hematopoietic stem cell development during embryogenesis, Curr. Opin. Immunol., 13, 166, 2001.
73. Delassus, S. and Cumano, A. Circulation of hematopoietic progenitors in the mouse embryo, Immunity, 4, 97, 1996.
74. Carding, S.C., et al., Developmentally regulated fetal thymic and extrathymic T-cell receptor γ/δ gene expression, Genes and Deve.opment, 4, 1320, 1990.
75. Schwartz, Z., Ornoy, A., and Soskolne, W.A. An in vitro assay of bone development using fetal long bones of mice: morphological studies, Acta Anat. (Basel), 124, 197, 1985.
76. Landreth, K.S. Critical windows in development of the rodent immune system, Hum. Exp. Toxicol., 21, 493, 2002.
77. Delassus, S., et al., Ontogeny of the heavy chain immunoglobulin repertoire in fetal liver and bone marrow, J. Immunol., 160, 3274, 1998.
78. Penit, C. and Vasseur, F. Cell proliferation and differentiation in the fetal and early postnatal mouse thymus, J. Immunol., 142, 3369, 1989.
79. Snodgrass, H.R., et al., Ontogeny of the T-cell antigen receptor within the thymus, Nature, 313, 592, 1985.
80. Xiao, S.Y., Li, Y., and Chen, W.F. Kinetics of thymocyte developmental process in fetal and neonatal mice, Cell Res., 13, 265, 2003.
81. Traver, D., et al., Fetal liver myelopoiesis occurs through distinct, prospectively isolatable progenitor subsets, Blood, 98, 627, 2001.
82. Spear, P.G., et al., Characterization of splenic lymphoid cells in fetal and newborn mice, J, Exp. Med., 138, 557, 1973.
83. Mosier, D.E. and Johnson, B.M., Ontogeny of mouse lymphocyte function. II. Development of the ability to produce antibody is modulated by T lymphocytes, J. Exp. Med., 141, 216, 1975.
84. Press, J.L., Neonatal immunity and somatic mutation, Int. Rev. Immunol., 19, 265, 2000.
85. Yellen, A.J., et al., Signaling through surface IgM in tolerance-susceptible immature murine B lymphocytes. Developmentally regulated differences in transmembrane signaling in splenic B cells from adult and neonatal mice, J Immunol., 146, 1446, 1991.
86. Yancopoulos, G.D. Malynn, B.A., and Alt, F.W., Developmentally regulated and strainspecific expression of murine VH gene families, J. Exp. Med., 168, 417, 1988.
87. Astori, M., et al., Development of T-B cell collaboration in neonatal mice, Int. Immunol., 11, 445, 1999.
88. Chelvarajan, R.L., et al., Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens, J. Leukoc. Biol., 75, 982, 2004.
89. Fadel, S. and Sarzotti, M. Cellular immune responses in neonates, Int. Rev. Immunol., 19, 173, 2000.
90. Adkins, B. Development of neonatal Th1/Th2 function, Int. Rev. Immunol., 19, 157, 2000.
91. Luster, M.I., et al., Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program’s guidelines for immunotoxicity evaluation in mice, Funamd.Appl. Toxicol. 10, 2, 1988.
92. Luster, M.I., et al., Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests, Fundam. Appl. Toxicol., 18, 200, 1992.
93. Luster, M.I., et al., Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests, Fundam. Appl. Toxicol., 21, 71, 1993.
94. Holladay, S.D. and Luster, M.I. Alterations in fetal thymic and liver hematopoietic cells as indicators of exposure to developmental immunotoxicants, Environ. Health Perspect., 104 Suppl. 4, 809, 1996.
95. Hardin, J.A., Hinoshita, F., and Sherr, D.H. Mechanisms by which benzo[a]pyrene, an environmental carcinogen, suppresses B cell lymphopoiesis, Toxicol. Appl. Pharmacol., 117, 155, 1992.
96. Kamath, A.B., Nagarkatti, P.S., and Nagarkatti, M. Characterization of phenotypic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocytes in vivo and its effect on apoptosis, Toxicol. Appl. Pharmacol., 150, 117, 1998.
97. Miyazaki, T., et al., Chlordane residues in human milk, Bull. Environ. Contam. Toxicol., 25, 518, 1980.
98. Spyker-Cranmer, J.M., et al., Immunoteratology of chlordane: cell and humoral immune responses in adult mice exposed in utero, Toxicol. Appl. Pharmacol., 62, 402, 1982.
99. Theus, S.A., Tabor, D.R., Barnett, J.B. Alteration of macrophage TNF production by prenatal chlordane exposure, FASEB J., 5, A1347, 1991.
100. Theus, S.A., et al., Macrophage tumoricidal mechanisms are selectively altered by prenatal chlordane exposure, Agents Actions 37, 140, 1992.
101. Barnett, J.B., et al., The effect of hexachlorobenzene on the developing immune response of BALB/c mice, Toxicol. Lett., 39, 263, 1987.
102. Urso, P., and Gengozian, N. Depressed humoral immunity and increased tumor incidence in mice following in utero exposure to benzo[a]pyrene, J. Toxicol. Environ. Health., 6, 569, 1980.
103. Urso, P., and Gengozian, N. Subnormal expression of cell-mediated and humoral immune responses in progeny disposed toward a high incidence of tumors after in utero exposure to benzo[a]pyrene, J. Tox. Environ. Health, 14, 569, 1984.
104. Weirda, D., et al., Perinatal immunotoxicity of benzene toward mouse B cell development, J. Amer. Coll. Toxicol., 8: 981, 1989.
105. Kalland, T. Reduced natural killer activity in female mice after neonatal exposure to diethylstilbestrol, J. Immunol., 124, 1297, 1980.
106. Kalland, T., Forsberg, J.G. Natural killer cell activity and tumor susceptibility in female mice treated neonatally with diethylstilbestrol, Cancer Res. 51, 134, 1981.
107. Luster, M.I., Faith, R.E., Kimmel, C.A. Depression of humoral immunity in rats following chronic developmental lead, J. Environ. Toxicol. 1: 397, 1978.
108. Faith, R.E., Luster, M.I., Kimmel, C.A. Effect of combined pre- and postnatal lead exposure on cell mediated immune functions, Clin. Exp. Immunol., 35, 413, 1979.
109. Caprio, R.J, Margulis, H.L., Joseloe, M.M. Lead absorpton in children and its relationship to urban traffic densities, Arch. Environ. Heath, 28, 195, 1974.
110. Miller, T.E., et al., Developmental exposure to lead causes persistent immunotoxicity in Fischer 344 rats, Toxicol. Sci. 42, 129, 1998.
111. Bunn, T.L., et al., Developmental immunotoxicology assessment in the rat: age, gender and strain comparisons after to exposure to Pb., Toxicol. Methods. 11, 41, 2000.
112. Bunn, T.L., Parsons, P.J., Dietert, R.R. Exposure to lead during critical windows of embryonic development: differential immunotoxic differential immunotoxic outcome based on stage of exposure and gender, Toxicol. Sci., 64, 57, 2000.
113. Pennicks, A.H., Pieters, H.H.H., Immunotoxicity of organotins, in Experimental Immunotoxicology, Smialowicz, R. J., Hollsapple, M. P., Eds., CRC Press, Boca Raton, FL. 1996, chap. 12.
114. Smialowicz, R.J., et al., Immunological effects of perinatal exposure of rats to di-n-octyltin dichloride, J. Toxicol.Environ. Health, 25, 403, 1988.
115. Smialowicz, R.J., et al., Immunotoxicity of tributyltin oxide in rats exposed as adults or pre-weanlings, Toxicology, 57, 97, 1989.
116. Poland, A., Knutson, J.C. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity, Ann. Rev.Pharm. Toxicol., 22, 517, 1989.
117. Holsapple, M.P. Immunotoxicity of halogenated aromatic hydrocarbons, in Experimental Immunotoxicology, Smialowicz, R.J., Hollsapple, M.P., Eds, CRC Press, Boca Raton, FL. 1996, chap. 14.
118. Schecter, A., et al., Congener-specific levels of dioxins and dibenzofurans in U.S. food and estimated daily dioxin equivalent intake, Environ. Health Pperspect., 102, 962, 1994.
119. Beck, H., et al., PCDD and PCDF body burdens from food intake in the Federal Republic of Germany, Chemosphere, 18, 417, 1989.
120. Furst, P., Furst, C., Groebel, W. Levels of PCDDs and PCDFs in food-stuffs from the Federal Rebublic of Germany, Chemosphere, 20, 787, 1990.
121. Theelen, R.M.C., et al., Intake of 2,3,7,8-tetrachlorodibenzo-p-dioxin, substituted dioxins, furans, and planar PCBs from food in the Netherlands: median and distribution, Chemosphere. 27, 1625, 1993.
122. Schecter, A., et al., Congener-specific levels of dioxin and dibenzofurans in U.S. food and estimated daily dioxin toxic equivalent intake, Environ. Health Perspect., 102, 962, 1994.
123. McLachlan, M.S. Digestive tract absorption of polychlorinated diobenzo-p-dioxins, dibenzofurans, and biphenyls in a nursing infant, Toxicol. Appl. Pharmacol., 123, 68, 1993.
124. Korte, M., Stahlmann, S.R., Neubert, D. Induction of hepatic monooxygenases in female rats and offspring in correlation with TCDD concentrations after single treatment during pregnancy, Chemosphere, 20, 1193, 1990.
125. Li, X., Weber, L.W.D., Rozman, K. K. Toxicokinetics of 2,3,7,8-tetrachlorodibenzo-pdioxin in female Sprague-Dawley rats including placental and lactation transfer to fetuses and neonates, Fund. Appl Toxicol., 27, 70, 1995.
126. Vos, J.G., Moore, J.A. Suppression of cellular immunity in rats and mice by maternal treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin, Int. Arch. Allergy, 47, 794, 1974.
127. Fine, J.S., Gasiewicz, T.A., Silverstone, A.E. Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol., 35, 18, 1989.
128. Gehrs, B.C., Smialowicz, R.J. Alterations in the developing immune system of the F344 rat after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. I. Effects on the fetus and the neonate, Toxicol., 122, 219, 1997.
129. Gehrs, B.C., Smialowicz, R.J. Persistent suppression of delayed-type hypersensitivity in adult F344 rats after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin, Toxicol., 134, 79, 1999.
130. Chapin, R.E., et al., The effects of perinatal/juvenile methoxychlor exposure on adult rat nervous, immune, and reproductive system function, Fundam. Appl. Toxicol., 40, 138, 1997.
131. Smialowicz, R.J., et al., Effect of perinatal/juvenile heptachlor exposure on adult immune and reproductive system function in rats. Toxicol. Sci., 61, 164, 2001.
132. Luebke, R.W., et al., The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J. Toxicol Environmental Health, Part B, 9: 1-26, 2006.